A Gene Transfer Study for Hemophilia A
Clinical trial NCT03003533 · COMPLETED
Trial details
- NCT number
- NCT03003533
- Sponsor
- Spark Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-26
- Primary completion
- 2023-12-05
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.